Zimmer Biomet Lowers Expectations for 2022

Zimmer Biomet reported 4Q21 orthopedic sales of $1.83 billion, -3.3% vs. 4Q20, and full-year 2021 orthopedic sales of $7.06 billion, +10.6% vs. 2020.

The company expects to complete the spin-off of its spine and dental businesses on March 1, 2022. The move originally came as Zimmer Biomet's first foray into active portfolio management...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0